These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11909727)

  • 21. Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists.
    Sielecki TM; Wityak J; Liu J; Mousa SA; Thoolen M; Wexler RR; Olson RE
    Bioorg Med Chem Lett; 2000 Mar; 10(5):449-52. PubMed ID: 10743945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists.
    Xue CB; Roderick J; Mousa S; Olson RE; DeGrado WF
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3499-504. PubMed ID: 9934460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
    Hamilton SF; Miller MW; Thompson CA; Dale GL
    J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments.
    Kam PC; Egan MK
    Anesthesiology; 2002 May; 96(5):1237-49. PubMed ID: 11981166
    [No Abstract]   [Full Text] [Related]  

  • 26. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
    Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
    Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists.
    Askew BC; Bednar RA; Bednar B; Claremon DA; Cook JJ; McIntyre CJ; Hunt CA; Gould RJ; Lynch RJ; Lynch JJ; Gaul SL; Stranieri MT; Sitko GR; Holahan MA; Glass JD; Hamill T; Gorham LM; Prueksaritanont T; Baldwin JJ; Hartman GD
    J Med Chem; 1997 Jun; 40(12):1779-88. PubMed ID: 9191954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cycloalkane spiroheterocyclic compounds. 9. 8-(1,2,3,4-Tetrahydro-2-naphthyl)-2-oxo-1-oxa-3,8-diazaspiro(4.5)decanes and related compounds.
    Maillard J; Langlois M; Delaunay P; Van TV; Chenu J; Morin R; Benharkate M; Manuel C; Motosso F
    J Med Chem; 1972 Nov; 15(11):1123-8. PubMed ID: 4654661
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
    Nannizzi-Alaimo L; Alves VL; Phillips DR
    Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors.
    Grumel V; Mérour JY; Lesur B; Giboulot T; Frydman A; Guillaumet G
    Eur J Med Chem; 2002 Jan; 37(1):45-62. PubMed ID: 11841874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
    Dickfeld T; Ruf A; Pogatsa-Murray G; Müller I; Engelmann B; Taubitz W; Fischer J; Meier O; Gawaz M
    Thromb Res; 2001 Jan; 101(2):53-64. PubMed ID: 11342206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men.
    Müller TH; Weisenberger H; Brickl R; Narjes H; Himmelsbach F; Krause J
    Circulation; 1997 Aug; 96(4):1130-8. PubMed ID: 9286940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
    Andronati SA; Krysko AA; Kabanov VM; Karaseva TL; Kabanova TA
    Acta Pol Pharm; 2000 Nov; 57 Suppl():15-21. PubMed ID: 11293251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Keating FK; Whitaker DA; Sobel BE; Schneider DJ
    Thromb Res; 2004; 113(1):27-34. PubMed ID: 15081562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
    Ferguson JJ; Zaqqa M
    Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in the research of GPIIb/IIIa antagonists.
    Xie Z; Cao C; Feng S; Huang J; Li Z
    Future Med Chem; 2015; 7(9):1149-71. PubMed ID: 26132524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
    Li YF; Spencer FA; Becker RC
    Am Heart J; 2002 Apr; 143(4):725-32. PubMed ID: 11923812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological control of platelet function.
    Clutton P; Folts JD; Freedman JE
    Pharmacol Res; 2001 Oct; 44(4):255-64. PubMed ID: 11592859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.